Colorectal cancer, which affects the colon and rectum, is one of the most common cancers worldwide and a major cause of ...

As a 12-year pancreatic cancer survivor, I share my journey through diagnosis, treatment and survival, hoping my story ...

Smoking has been linked to pancreatic cancer, but the reasons were unclear. A new mouse study shows that chemicals in ...

Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...

Pancreatic cancer is one of the deadliest forms of cancer with a poor prognosis rate. But a new study suggests that a vaccine ...

Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Revolution Medicines (Nasdaq: RVMD) said Tuesday that it is advancing daraxonrasib into Phase III testing for pancreatic ...

The Early Diagnosis Pancreatic Programme is aiming to improve survival rates for people with pancreatic cancer. To do this, the team works to develop new strategies and deliver programmes targeted at ...

ALL medications, including prescription drugs, over-the-counter medicines, and even herbal remedies, have the potential to ...

Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical activity and durability ...

To combat surging rates of early-onset GI cancer, experts suggest a new approach combining lower screening thresholds and ...